- ICH GCP
- US Clinical Trials Registry
- Clinical Trial Page
Clinical Care Consortium of Telomere-Associated Ailments (CCCTAA) Database
Clinical Care Consortium of Telomere-Associated Ailments (CCCTAA) Database
Sponsors |
Lead Sponsor: National Cancer Institute (NCI) |
---|---|
Source | National Institutes of Health Clinical Center (CC) |
Brief Summary | Study Description: This protocol will be utilized for the creation and management of a repository of coded clinical data on patients with Telomere Biology Disorders (TBDs) submitted by researchers from CCCTAA member institutions. Objective: The primary objective of this study is to develop a shared database (repository) of coded clinical research data, managed by NCI, to facilitate collaborative research across CCCTAA member institutions. |
Detailed Description | Study Description: This protocol will be utilized for the creation and management of a repository of coded clinical data on patients with Telomere Biology Disorders (TBDs) submitted by researchers from CCCTAA member institutions. Objective: The primary objective of this study is to develop a shared database (repository) of coded clinical research data, managed by NCI, to facilitate collaborative research across CCCTAA member institutions. |
||||||||
---|---|---|---|---|---|---|---|---|---|
Overall Status | Recruiting | ||||||||
Start Date | 2022-07-12 | ||||||||
Completion Date | 2037-12-31 | ||||||||
Primary Completion Date | 2037-12-31 | ||||||||
Study Type | Observational | ||||||||
Primary Outcome |
|
||||||||
Enrollment | 10000 |
Condition | |
---|---|
Eligibility |
Sampling Method: Non-Probability Sample
Criteria:
- INCLUSION CRITERIA: In order to be eligible to participate in this study, an individual must meet all of the following criteria: - Diagnosed or being evaluated for a Telomere Biology Disorder (TBD) at a CCCTAA member institution. - Male or female, from 0 to 100 years. EXCLUSION CRITERIA: An individual who meets any of the following criteria will be excluded from participation in this study: -Individuals who do not meet eligibility criteria. No other exclusionary criteria apply. Gender: All Minimum Age: N/A Maximum Age: N/A Healthy Volunteers: No |
Overall Official |
|
||||||
---|---|---|---|---|---|---|---|
Overall Contact |
Last Name: Cecilia P Higgs Phone: (240) 276-7627 Email: cecilia.higgs@nih.gov |
||||||
Location |
|
Location Countries |
United States |
---|---|
Verification Date |
2022-06-23 |
Responsible Party |
Type: Sponsor |
Keywords | |
Has Expanded Access | No |
Condition Browse | |
Arm Group |
Label: Patients Description: A cohort of participants who have or are suspected of having a telomere biology disorder |
Study Design Info |
Observational Model: Cohort Time Perspective: Other |
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on
-
NCT05808231RecruitingConditions: COVID-19
-
NCT05807139Not yet recruitingConditions: Alcohol Use Disorder
-
NCT05808322Not yet recruitingConditions: COVID-19
-
NCT05807126Not yet recruitingConditions: Advanced Malignant Solid Neoplasm, Metastatic Malignant Solid Neoplasm, Recurrent Malignant Solid Neoplasm
-
NCT05808413Not yet recruitingConditions: Vaccine Refusal, COVID-19
-
NCT05808400RecruitingConditions: Long COVID-19 Syndrome
-
NCT05808361CompletedConditions: Rehabilitation, Pneumonia, Viral, COVID-19, Quality of Life
-
NCT05808348RecruitingConditions: Pain, Fear, Falling, Physical Activity, COVID-19, Aged
-
NCT05805566Not yet recruitingConditions: Post-Covid Syndrome
-
NCT05803395Not yet recruitingConditions: Chronic Lymphocytic Leukemia, Indolent B-Cell Non-Hodgkin Lymphoma, COVID-19